VBCG
ZBH icon

Valley Brook Capital Group’s Zimmer Biomet ZBH Stock Holding History

Valley Brook Capital Group’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-731
Closed -$113K – 448
2021
Q1 		$113K Buy
731
+25
+4% +$3.87K 0.1% 150
2020
Q4 		$105K Buy
+706
New +$99.7K 0.1% 143

Other funds holding ZBH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Valley Brook Capital Group's ZBH Position: Q2 2021 in Review

Valley Brook Capital Group sold out of Zimmer Biomet (ZBH) in Q2 2021, closing a stake of 731 shares — an estimated $113K sold.

Valley Brook Capital Group first reported a position in ZBH in Q4 2020 and held it in 2 quarters. The position peaked at $113K in Q1 2021. 1,018 funds tracked by Wall St. Rank hold ZBH as of Q2 2021.

  • Valley Brook Capital Group reported no remaining Zimmer Biomet position as of Q2 2021 after selling out during the quarter.
  • Valley Brook Capital Group sold 731 Zimmer Biomet shares in Q2 2021, an estimated $113K.
  • Valley Brook Capital Group first reported a position in Zimmer Biomet in Q4 2020 and held it in 2 quarters.
  • Valley Brook Capital Group's Zimmer Biomet position peaked at $113K in Q1 2021.
  • 1,018 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2021.

Based on Valley Brook Capital Group's 13F filing for Q2 2021, filed 22 Jul 2021.